Where does Dina Chaya work?

Dina Chaya is Partner at OrbiMed and Founder at Spruce Biosciences.

What check size does Dina Chaya write?

Dina Chaya typically writes checks of $100K – $5M.

What companies did Dina Chaya found?

Dina Chaya founded Spruce Biosciences.

Dina Chaya

InvestorFounder

Partner at OrbiMed · Board director at Spruce Biosciences

London

Writes $100K – $5M checks · typically $1.5M

FoundedSpruce Biosciences

About

Dina Chaya is a Partner on the Private Equity team at OrbiMed, with healthcare investment experience in Europe and the US since 2001 across private equity and venture capital. Her prior roles include positions at Omega Funds, NeoMed Management, 3i Group, and Index Ventures, and her portfolio includes investments in companies acquired by Merck, AstraZeneca, Alexion Pharmaceuticals, and Jazz Pharmaceuticals. Chaya holds a CFA charter and a Ph.D. in Molecular and Cellular Biology from Paris VI University, with postdoctoral research experience at Brown University and Fox Chase Cancer Centre.

Board director at Spruce Biosciences

Intro paths

→

In turn, Dina can intro founders to Spruce Biosciences's investors below.

Spruce Biosciences's investors · 6

AbingworthLondon · $15M – $30M checks · since 2025 Aisling CapitalNew York HealthCapStockholm · since 2020 Norwest Venture PartnersMenlo Park · $10M – $30M checks · since 2025 OrbiMedNew York · $1M – $75M checks · since 2020 RiverVest Venture PartnersSt. Louis · $500K – $3M checks · since 2020

Co-founders at Spruce Biosciences

Javier SzwarcbergExecutive Officer, Director

Samir GharibExecutive Officer

RICHARD KINGExecutive Officer, Director

Experience

OrbiMedPartnercurrent2023 — presentLondon, United Kingdom
Monks Investment Trust PLCBoard Director2022 — 2025
Omega FundsPartner2017 — 2023
NeoMedPartner2009 — 2023
Invest EuropeMember of the Venture Capital Platform Council2018 — 2022
3i Group plcDirector Growth Capital / Venture Capital2004 — 2008
Index VenturesAssociate2001 — 2004
Fox Chase Cancer CenterPostdoctoral Fellow2000 — 2001
Brown UniversityPostdoctoral Fellow1998 — 2000

Education

CFA InstituteChartered Financial Analyst Degree, Finance2002 — 2004
Pierre and Marie Curie UniversityPhD, Molecular & Cellular Biology of Development1994 — 1997
Pierre and Marie Curie UniversityDEA, Molecular & Cellular Biology of Development1993 — 1994
University of CambridgeBA in Natural Sciences, Natural Sciences1990 — 1993

Skills & more

Venture Capital29Private Equity22Start-ups14Investments12Pharmaceutical Industry3Growth Capital6Medical Devices6Due Diligence7Corporate Development13Valuation3MergersFunding3

+3 more

EntrepreneurshipBusiness StrategyInvestment Banking

From Dina's professional profile.

Deals · 1

Spruce BiosciencesBoard seat

via OrbiMed · filed Feb 2023 · $53.6M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at OrbiMed

Venture Partner at OrbiMed

Andrew P. Kanarek, CFA, CIPM

Network4

Alexandria Huynh

Analyst at OrbiMed

Anat Nursella

Venture Partner at OrbiMed

Investors connected to Dina in public investor directories — a warm-intro map.

Frequently asked questions

Where does Dina Chaya work?: Dina Chaya is Partner at OrbiMed and Founder at Spruce Biosciences.
What check size does Dina Chaya write?: Dina Chaya typically writes checks of $100K – $5M.
What companies did Dina Chaya found?: Dina Chaya founded Spruce Biosciences.

Same school

Also attended CFA Institute334

Matt CherianVenture Partner at Monta Vista Capital Laviva MazharPrincipal at Luge Capital Jan AvontsInvestment Director at Capricorn Venture Partners Matias BarberoVenture Partner at FJ Labs Kim RobertsonFinancial Manager at 4Di Capital Cole LundquistPrincipal at QED Investors

+ 328 more

Also attended Pierre and Marie Curie University48

Jeff ClavierFounding Partner at Uncork Capital Jean SiniGeneral Partner at Partech Ventures Dimitri KrempPrincipal at Axeleo Capital Jack GuedjInvestor at Sand Hill Angels Ophélie LaurinInvestment Associate at World Fund Rémi DrollerManaging Partner at Kurma Partners

+ 42 more

Also attended University of Cambridge851

Niko BonatsosInvestment Team at General Catalyst Georgia StevensonInvestor at Index Ventures Hannah SealInvestor at Index Ventures Leah von SiemensPartner at Manta Ray Ventures Anthony PhilippakisInvestor at GV (Google Ventures)Erik NordlanderInvestor at GV (Google Ventures)

+ 845 more

Shared employers

Also worked at Omega Funds15

Nessan BerminghamInvestor at Khosla Ventures Liam FlahertyInvestor at Silversmith Capital Partners Richard LimManaging Partner at Cure Ventures Annie MitsakPartner at Cure Ventures John MaraganoreAdvisor at Oak HC/FT Keno GutierrezGeneral Partner at BioGeneration Ventures

+ 9 more

Also worked at 3i Group plc78

Sean BrownleePartner at Rho Ventures Giuseppe DonvitoPartner at P101 Ventures Marco FumagalliBoard Member at P101 Ventures Andrea ScholzSenior Executive Assistant at Sapphire Ventures Jan-Olivier FillolsSenior Managing Director at Marlin Equity Partners Jeremy NakacheManaging Director at Marlin Equity Partners

+ 72 more

Also worked at Index Ventures121

Danny RimerPartner at Index Ventures Adrianna MaInvestor at Index Ventures Ali Fisher SweetInvestor at Index Ventures Ana AndreescuInvestor at Index Ventures André DuboisInvestor at Index Ventures Avron MarcusInvestor at Index Ventures

+ 115 more

Also worked at Fox Chase Cancer Center2

Ricardo SalomãoGeneral Partner at Greenrock Capital Mark FeitelsonFounder at SFA Therapeutics